Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient’s COVID-19 Infection
Multiple sclerosis (MS) and its various comorbidities that may be observed are of great interest due to the complexity of MS pathophysiology and all of the immunological changes that follow. The incidence of cancer in MS has been investigated for several years, as not only does it affect ongoing the...
Main Authors: | Nikolaos Markoglou, George Simeakis, Maria Alevizaki, Georgios Velonakis, Theofanis Chatzistamatiou, Maria Spyropoulou-Vlachou, Catherine Stavropoulos-Giokas, Leonidas Stefanis, Maria Anagnostouli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/11/2850 |
Similar Items
-
<i>HLA-DPB1*03</i> as Risk Allele and <i>HLA-DPB1*04</i> as Protective Allele for Both Early- and Adult-Onset Multiple Sclerosis in a Hellenic Cohort
by: Maria Anagnostouli, et al.
Published: (2020-06-01) -
Evaluation of HLA-G Expression in Multipotent Mesenchymal Stromal Cells Derived from Vitrified Wharton’s Jelly Tissue
by: Panagiotis Mallis, et al.
Published: (2018-11-01) -
Multiple Endocrine Neoplasia in Childhood: An Update on Diagnosis, Screening, Management and Treatment
by: Marianne Jacob, et al.
Published: (2022-02-01) -
Management and Long-Term Follow-Up of Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1: Single Center Experience
by: Maria P. Yavropoulou, et al.
Published: (2022-04-01) -
Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients
by: Francesca Marini, et al.
Published: (2018-11-01)